A Leap Forward – All Oral Regimens Revolutionizing Multidrug-resistant Tuberculosis Treatment

QR Code

A Leap Forward – All Oral Regimens Revolutionizing Multidrug-resistant Tuberculosis Treatment

Saved in:

Bibliographic Details
Main Author:	Durga Balagopalan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Journal of Advanced Lung Health
Online Access:	https://journals.lww.com/10.4103/jalh.jalh_23_25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Industrial Leap Forward in EAEU Requires Cooperation of Production and Innovative Projects
by: Article Editorial
Published: (2019-12-01)

Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India
by: Hindol Mondal, et al.
Published: (2025-07-01)

Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance
by: N. Yu. Nikolenko, et al.
Published: (2023-07-01)

Women’s Movement in Late 1880s and 1890s in Britain: A Stagnation Era or a Leap Forward?
by: E. O. Naumenkova
Published: (2025-02-01)

Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
by: Abhishek Saini, et al.
Published: (2025-07-01)

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.
by: James C Johnston, et al.
Published: (2009-09-01)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021-07-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

Prediction of risk factors associated with the development of multidrug-resistant tuberculosis in patients with tuberculosis
by: Haiyan Chen, et al.
Published: (2025-07-01)

Gut microbiota of HIV-infected patients with multidrug-resistant tuberculosis
by: L. Yu. Otdushkina, et al.
Published: (2022-12-01)

The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.
by: Adel Hussein Elduma, et al.
Published: (2023-01-01)

A LEAP Forward in Wildlife Conservation: A Standardized Framework to Determine Mortality Causes in Large GPS‐Tagged Birds
by: Connor T. Panter, et al.
Published: (2025-04-01)

Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
by: A. K. Strelis, et al.
Published: (2009-02-01)

Beyond treatment and cure: Burden of adverse drug reactions in a case of multidrug-resistant tuberculosis
by: Sagarika N. Suresh, et al.
Published: (2025-01-01)

Correction: The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.
by: Adel Hussein Elduma, et al.
Published: (2024-01-01)

Resurgence of multidrug-resistant tuberculosis during the COVID-19 pandemic in Korea
by: Tae Hoon Kim, et al.
Published: (2025-06-01)

Efficacy and safety of treatment of HIV-associated multidrug-resistant tuberculosis. Systematic review and meta-analysis
by: A. V. Kukurika
Published: (2025-03-01)

Taking the quantum leap : the new physics for nonscientists /
by: Wolf, Fred Alan
Published: (1981)

Molecular Biological Techniques for Detection of Multidrug Resistant Tuberculosis (MDR) and Extremely Drug Resistant Tuberculosis (XDR) in Clinical Isolates of Mycobacterium tuberculosis
by: Therese, K.L., et al.
Published: (2012)

Sociodemographic determinants of multidrug-resistant tuberculosis in Lesotho: A case-control study.
by: Jerry Yakubu Yahaya
Published: (2025-01-01)

Sociodemographic determinants of multidrug-resistant tuberculosis in Lesotho: A case-control study
by: Jerry Yakubu Yahaya
Published: (2025-01-01)

A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment.
by: Chunling Lu, et al.
Published: (2013-01-01)

A new model for the dental assistant recruitment: A leap forward in the functionality of online community groups among the dental workers in Taiwan
by: Feng-Chou Cheng, et al.
Published: (2025-07-01)

Mixed infections and heteroresistance of Mycobacterium tuberculosis among multidrug-resistant tuberculosis in China: a genomic epidemiology study
by: Yanping Liu, et al.
Published: (2025-12-01)

V-ATPase Inhibitors in Cancer Treatment and Their Implication in Multidrug Resistance in Oral Squamous Cell Carcinoma
by: Pérez-Sayáns, Mario, et al.
Published: (2011)

Predictors of failure in treatment according program DOTS-PLUS in patients suffering from multidrug-resistant tuberculosis
by: I. G. Felker, et al.
Published: (2012-08-01)

Factors influencing the risk of developing multidrug-resistant pulmonary tuberculosis in Northeast Thailand
by: Nion Leeka, et al.
Published: (2025-08-01)

Multidrug resistant tuberculosis in prisons located in former Soviet countries: A systematic review.
by: Maxwell Droznin, et al.
Published: (2017-01-01)

PRIMARY MULTIDRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIUM ACCORDING TO DATA OF KRASNOYARSK REGIONAL TUBERCULOSIS DISPENSARY № 1 IN-PATIENT DEPARTMENT
by: N. M. Koretskaya, et al.
Published: (2012-09-01)

Comprehensive evaluation of the MeltPro MTB/PZA assay for prediction of pyrazinamide resistance in multidrug-resistant tuberculosis
by: Guiqing He, et al.
Published: (2025-07-01)

Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.
by: Jia Yin, et al.
Published: (2016-01-01)

Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
by: Beena Elizabeth Thomas, et al.
Published: (2016-01-01)

Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
by: А. Yu. Savchenko, et al.
Published: (2024-01-01)

Adverse events reported with BPaL and BPaLM regimens in drug-resistant tuberculosis
by: Kannan Sridharan, et al.
Published: (2025-08-01)

“Springboard” — a Conceptual Leap into Field of Regional Media
by: E. S. Radiontseva
Published: (2023-04-01)

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis
by: Tomasz Bogiel, et al.
Published: (2025-06-01)

Multidrug Resistence and Breast Cancer
by: Zhou, Gengyin, et al.
Published: (2012)